Total Payments
$86,794
2024 Payments
$6,813
Companies
55
Transactions
553
Medicare Patients
3,545
Medicare Billing
$354,272
Payment Breakdown by Category
Other$60,719 (70.0%)
Consulting$13,193 (15.2%)
Food & Beverage$10,352 (11.9%)
Travel$2,402 (2.8%)
Education$128.64 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,819 | 33 | 68.9% |
| Consulting Fee | $13,193 | 13 | 15.2% |
| Food and Beverage | $10,352 | 491 | 11.9% |
| Travel and Lodging | $2,402 | 12 | 2.8% |
| Honoraria | $900.00 | 1 | 1.0% |
| Education | $128.64 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $62,678 | 111 | $0 (2024) |
| GENZYME CORPORATION | $14,465 | 46 | $0 (2021) |
| Genentech, Inc. | $1,060 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $950.33 | 72 | $0 (2024) |
| BANNER LIFE SCIENCES, LLC | $900.00 | 1 | $0 (2021) |
| EMD Serono, Inc. | $773.47 | 22 | $0 (2024) |
| ABBVIE INC. | $657.09 | 38 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $622.47 | 18 | $0 (2024) |
| Horizon Therapeutics plc | $555.73 | 25 | $0 (2023) |
| Nevro Corp. | $548.94 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,813 | 92 | Biogen, Inc. ($4,783) |
| 2023 | $10,836 | 63 | Biogen, Inc. ($9,838) |
| 2022 | $18,018 | 75 | Biogen, Inc. ($16,956) |
| 2021 | $15,586 | 85 | Biogen, Inc. ($12,677) |
| 2020 | $21,390 | 55 | Biogen, Inc. ($17,540) |
| 2019 | $11,848 | 66 | GENZYME CORPORATION ($10,678) |
| 2018 | $1,411 | 64 | Biogen, Inc. ($351.02) |
| 2017 | $889.86 | 53 | Biogen, Inc. ($265.61) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $202.31 | General |
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $90.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Neurology | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.53 | General |
| 11/13/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/08/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| 10/30/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/23/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 846 | 993 | $323,593 | $84,470 |
| 2022 | 12 | 927 | 1,073 | $375,610 | $96,742 |
| 2021 | 17 | 947 | 1,138 | $367,386 | $102,316 |
| 2020 | 16 | 825 | 941 | $273,200 | $70,744 |
Total Patients
3,545
Total Services
4,145
Medicare Billing
$354,272
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 87 | 135 | $54,000 | $18,686 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 83 | 83 | $36,910 | $9,188 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 83 | $24,485 | $8,718 | 35.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 137 | 171 | $20,520 | $6,338 | 30.9% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 41 | 42 | $34,944 | $6,225 | 17.8% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 44 | 46 | $29,440 | $4,896 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 51 | 52 | $15,340 | $4,255 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $13,150 | $4,160 | 31.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 30 | 38 | $9,500 | $3,188 | 33.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $9,765 | $2,914 | 29.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 28 | $7,980 | $2,712 | 34.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 13 | 14 | $18,060 | $2,530 | 14.0% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2023 | 20 | 20 | $15,360 | $2,468 | 16.1% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 24 | 25 | $12,800 | $2,085 | 16.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 107 | 128 | $6,400 | $1,876 | 29.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 22 | 26 | $4,160 | $1,393 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,870 | $1,017 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 14 | $2,870 | $776.02 | 27.0% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 11 | 11 | $4,224 | $719.18 | 17.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 12 | 12 | $815.00 | $323.88 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 86 | 131 | $52,400 | $17,988 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 82 | 82 | $36,465 | $9,338 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $26,055 | $8,328 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 74 | $21,830 | $7,475 | 34.2% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 43 | 43 | $35,776 | $6,713 | 18.8% |
About Dr. Braeme Glaun, M.D
Dr. Braeme Glaun, M.D is a Neurology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154371482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Braeme Glaun, M.D has received a total of $86,794 in payments from pharmaceutical and medical device companies, with $6,813 received in 2024. These payments were reported across 553 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,819).
As a Medicare-enrolled provider, Glaun has provided services to 3,545 Medicare beneficiaries, totaling 4,145 services with total Medicare billing of $354,272. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Baltimore, MD
- Active Since 05/10/2006
- Last Updated 11/28/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1154371482
Products in Payments
- TYSABRI (Biological) $25,396
- AUBAGIO (Drug) $14,165
- VUMERITY (Drug) $10,616
- Tysabri (Biological) $5,849
- TECFIDERA (Drug) $3,728
- OCREVUS (Biological) $1,170
- BAFIERTAM (Drug) $900.00
- UPLIZNA (Drug) $555.73
- AIMOVIG (Biological) $383.34
- QULIPTA (Drug) $363.26
- KESIMPTA (Drug) $347.60
- Omnia (Device) $344.78
- BOTOX (Biological) $344.10
- LEMTRADA (Drug) $316.00
- SOLIRIS (Drug) $254.89
- Senza (Device) $204.16
- Soliris (Drug) $185.35
- Hizentra (Biological) $185.01
- UBRELVY (Drug) $176.33
- ZEPOSIA (Drug) $175.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Baltimore
Dr. Scott Newsome, D.o, D.O
Neurology — Payments: $315,913
Neurology $315,913
Dr. Shiv Saidha, Mbbch, MBBCH
Neurology — Payments: $302,214
Neurology $302,214
Thomas Crawford, M.d, M.D
Neurology — Payments: $277,464
Neurology $277,464
Dr. Perry Foreman, M.d, M.D
Neurology — Payments: $249,906
Neurology $249,906
Santiago Mazuera Mejia, M.d, M.D
Neurology — Payments: $221,999
Neurology $221,999
Samuel Miller, M.d, M.D
Neurology — Payments: $185,408
Neurology $185,408